The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.26BCNY
484.79M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue (TTM)
1.61BCNY
239.64M · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
-8.15%
vs Footwear & Accessories peers
Updated Aug 21, 2026
Beta
0.5130x
vs all stocks
Updated Aug 21, 2026
52-Week Change
-16.53%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
3.26BCNY
484.79M · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
2.72BCNY
404.70M · vs all stocks (USD)
Updated Aug 21, 2026
Forward P/E
12.51x
vs Footwear & Accessories peers
Updated Aug 21, 2026
Price to Sales (TTM)
2.02x
vs Footwear & Accessories peers
Updated Aug 21, 2026
Price to Book (MRQ)
1.38x
vs Footwear & Accessories peers
Updated Aug 21, 2026
Enterprise to Revenue
1.69x
vs Footwear & Accessories peers
Updated Aug 21, 2026
Enterprise to EBITDA
-24.97x
vs Footwear & Accessories peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 154.03×.Updated Aug 21, 2026
Gross Margin
41.36%
vs Footwear & Accessories peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 39.27%.Updated Aug 21, 2026
Profit Margin
-8.15%
vs Footwear & Accessories peers
Updated Aug 21, 2026
Operating Margin
-5.92%
vs Footwear & Accessories peers
Updated Aug 21, 2026
Return on Assets (TTM)
-2.85%
vs Footwear & Accessories peers
Updated Aug 21, 2026
Return on Equity (TTM)
-5.49%
vs Footwear & Accessories peers
Updated Aug 21, 2026
Revenue (TTM)
1.61BCNY
239.64M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
4.02CNYUpdated Aug 21, 2026
Quarterly Revenue Growth
-30.40%
vs Footwear & Accessories peers
Updated Aug 21, 2026
Gross Profit (TTM)
632.78MCNY
94.10M · vs all stocks (USD)
Updated Aug 21, 2026
EBITDA (TTM)
17.67MCNY
2.63M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
-131.41MCNY
-19.54M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
-42.05%
vs Footwear & Accessories peers
Updated Aug 21, 2026
Operating Cash Flow (TTM)
492.45MCNY
73.23M · vs all stocks (USD)
Updated Aug 21, 2026
Levered Free Cash Flow (TTM)
706.69MCNY
105.09M · vs all stocks (USD)
Updated Aug 21, 2026
5-Year Average Dividend Yield
5.73%
vs all stocks
Updated Aug 21, 2026
Payout Ratio
0.00%
vs Footwear & Accessories peers
Updated Aug 21, 2026
Minority Interest (Equity)
891.84KCNYFY2025 · Dec 31, 2025
Revenue
1.92BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.25BCNYFY2025 · Dec 31, 2025
Gross Profit
670.94MCNYFY2025 · Dec 31, 2025
Operating Income
-247.81MCNY
-36.85M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-245.46MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-1.53MCNYFY2025 · Dec 31, 2025
Net Income
-243.93MCNYFY2025 · Dec 31, 2025
EBIT
-237.73MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
17.67MCNYFY2025 · Dec 31, 2025
Research & Development
29.90MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
294.77MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
14.60MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
5.21MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
7.73MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.6011CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.6011CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
400.97MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
400.97MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-243.93MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
2.91MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
280.36MCNYFY2025 · Dec 31, 2025
Free Cash Flow
242.85MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
529.09MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-243.93MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
81.20MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
142.14MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
300.95MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-37.51MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-234.82MCNYFY2025 · Dec 31, 2025
Sale of Investments
236.84MCNYFY2025 · Dec 31, 2025
Other Investing Activity
7.37MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-28.11MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
102.10MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-77.68MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-62.25MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-150.50MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-188.33MCNYFY2025 · Dec 31, 2025
Shares Outstanding
400.98MSharesUpdated Aug 21, 2026
Float Shares
171.69MSharesUpdated Aug 21, 2026
% Held by Insiders
61.38%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
2.06%
vs all stocks
Updated Aug 21, 2026
Total Cash (MRQ)
651.01MCNY
96.81M · vs all stocks (USD)
Updated Aug 21, 2026
Total Cash per Share (MRQ)
1.62CNYUpdated Aug 21, 2026
Total Debt (MRQ)
113.03MCNY
16.81M · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
0.0479x
vs Footwear & Accessories peers
Updated Aug 21, 2026
Current Ratio (MRQ)
2.70x
vs Footwear & Accessories peers
Updated Aug 21, 2026
Book Value per Share (MRQ)
5.89CNYUpdated Aug 21, 2026
Total Assets
3.13BCNY
465.67M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.85BCNYFY2025 · Dec 31, 2025
Total Liabilities
784.81MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.28BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
31.59MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
753.22MCNYFY2025 · Dec 31, 2025
Cash
608.71MCNYFY2025 · Dec 31, 2025
Cash Equivalents
7.29MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
616.00MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
5.00MCNYFY2025 · Dec 31, 2025
Accounts Receivable
713.61MCNYFY2025 · Dec 31, 2025
Inventory
367.15MCNYFY2025 · Dec 31, 2025
Accounts Payable
462.85MCNYFY2025 · Dec 31, 2025
Short-term Debt
113.10MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
7.90MCNYFY2025 · Dec 31, 2025
Long-term Debt
24.82MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
400.98MCNYFY2025 · Dec 31, 2025
Retained Earnings
-150.19MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.35BCNY
348.96M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
5.37CNYUpdated Aug 21, 2026
52-Week High
14.14CNYUpdated Aug 21, 2026
52-Week Change
-16.53%
vs all stocks
Updated Aug 21, 2026
Beta
0.5130x
vs all stocks
Updated Aug 21, 2026
50-Day MA
8.85CNYUpdated Aug 21, 2026
200-Day MA
9.11CNYUpdated Aug 21, 2026
Avg 10-Day Volume
13.88MSharesUpdated Aug 21, 2026
Avg 30-Day Volume
18.07MSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
-0.3300CNYUpdated Aug 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.41Profit Margin: -0.08
Financial Health
Altman Z-Score 3.21: safe zoneNotable
Altman Z-Score: 3.21
High earnings qualityNotable
Earnings Quality Score: 0.65
Supply Chain
Upstream position: supplies 5 industries, depends on 2Notable
Outgoing: 5.00Incoming: 2.00
Scale
Levered free cash flow is $105.09M, above the global median of $16.24MNotable